DHR - DANAHER CORP /DE/


204.73
0.720   0.352%

Share volume: 2,956,604
Last Updated: 03-04-2026
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: 0.03%

PREVIOUS CLOSE
CHG
CHG%

$204.01
0.72
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
60%
Profitability 57%
Dept financing 44%
Liquidity 27%
Performance 76%
Company vs Stock growth
vs
Performance
5 Days
-0.62%
1 Month
-5.11%
3 Months
-9.51%
6 Months
2.26%
1 Year
-2.77%
2 Year
-19.52%
Key data
Stock price
$204.73
P/E Ratio 
44.74
DAY RANGE
$203.04 - $206.78
EPS 
$5.07
52 WEEK RANGE
$171.00 - $242.80
52 WEEK CHANGE
-$4.69
MARKET CAP 
161.698 B
YIELD 
0.56%
SHARES OUTSTANDING 
707.139 M
DIVIDEND
$0.40
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
07-22-2025
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,405,413
AVERAGE 30 VOLUME 
$4,257,629
Company detail
CEO: Rainer M. Blair
Region: US
Website: danaher.com
Employees: 81,000
IPO year: 1987
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.

Recent news